---
title: "Psyence Biomedical Ltd. (PBM.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/PBM.US.md"
symbol: "PBM.US"
name: "Psyence Biomedical Ltd."
industry: "Biotechnology"
---

# Psyence Biomedical Ltd. (PBM.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.psyencebiomed.com](https://www.psyencebiomed.com) |

## Company Profile

Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company’s lead product candidate is P...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.58 | 149/604 | 6.63 | 1.97 | 1.77 |
| PB | 0.19 | 8/604 | 0.36 | 0.27 | 0.22 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/PBM.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/PBM.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/PBM.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.